Squarepoint Ops LLC Abb Vie Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 95,322 shares of ABBV stock, worth $16.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

95,322

Previous 116,779 18.37%

Holding current value

$16.7 Million

Previous $20 Million 6.02%

% of portfolio

0.03%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $3.52 Million - $4.28 Million	-21,457 Reduced 18.37%	95,322 $18.8 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $10.7 Million - $12.5 Million	68,898 Added 143.89%	116,779 $20 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $30.1 Million - $34.3 Million	-188,544 Reduced 79.75%	47,881 $8.72 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $31.5 Million - $35.4 Million	-228,575 Reduced 49.16%	236,425 $36.6 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $61.6 Million - $76.7 Million	465,000 New	465,000 $62.6 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $8.92 Million - $10.7 Million	64,515 New	64,515 $10.4 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $855,572 - $1.08 Million	7,964 Added 9.07%	95,810 $13 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $33.8 Million - $38.3 Million	-317,309 Reduced 78.32%	87,846 $9.48 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $18.7 Million - $20.9 Million	178,115 Added 78.45%	405,155 $45.6 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $588,531 - $647,902	5,753 Added 2.6%	227,040 $24.6 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $5.36 Million - $7.24 Million	-66,590 Reduced 23.13%	221,287 $23.7 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $8.67 Million - $10.2 Million	100,899 Added 53.96%	287,877 $25.2 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $11 Million - $14.8 Million	150,553 Added 413.32%	186,978 $18.4 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $8.45 Million - $12.8 Million	-131,072 Reduced 78.25%	36,425 $2.78 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $510,948 - $653,112	7,777 Added 4.87%	167,497 $12.2 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $12.3 Million - $14.5 Million	159,720 New	159,720 $12.9 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $8.09 Million - $9.97 Million	-103,883 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $32.6 Million - $36.2 Million	-366,468 Reduced 77.91%	103,883 $9.83 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $27.3 Million - $32.3 Million	303,659 Added 182.17%	470,351 $43.6 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $15.3 Million - $20.5 Million	166,692 New	166,692 $15.8 Million

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Abb Vie Inc. Transaction History